Suppr超能文献

慢性伤口中M2巨噬细胞的治疗特性:生物材料辅助M2巨噬细胞靶向治疗的创新领域。

Therapeutic Properties of M2 Macrophages in Chronic Wounds: An Innovative Area of Biomaterial-Assisted M2 Macrophage Targeted Therapy.

作者信息

Nazari Mahdis, Taremi Siavash, Elahi Reza, Mostanadi Parsa, Esmeilzadeh Abdolreza

机构信息

School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

Department of Immunology, Zanjan University of Medical Sciences, Zanjan, Iran.

出版信息

Stem Cell Rev Rep. 2025 Feb;21(2):390-422. doi: 10.1007/s12015-024-10806-3. Epub 2024 Nov 18.

Abstract

Wound healing is a dynamic, multi-stage process essential for restoring skin integrity. Dysregulated wound healing is often linked to impaired macrophage function, particularly in individuals with chronic underlying conditions. Macrophages, as key regulators of wound healing, exhibit significant phenotypic diversity, ranging from the pro-healing M2 phenotype to the pro-inflammatory M1 phenotype. Imbalances in the M1/M2 ratio or hyperactivation of the M1 phenotype can delay the normal healing. Consequently, strategies aimed at suppressing the M1 phenotype or promoting the shift of local skin macrophages toward the M2 phenotype can potentially treat chronic non-healing wounds. This manuscript provides an overview of macrophages' role in normal and pathological wound-healing processes. It examines various therapeutic approaches targeting M2 macrophages, such as ex vivo-activated macrophage therapy, immunopharmacological strategies, and biomaterial-directed macrophage polarization. However, it also highlights that M2 macrophage therapies and immunopharmacological interventions may have drawbacks, including rapid phenotypic changes, adverse effects on other skin cells, biotoxicity, and concerns related to biocompatibility, stability, and drug degradation. Therefore, there is a need for more targeted macrophage-based therapies that ensure optimal biosafety, allowing for effective reprogramming of dysregulated macrophages and improved therapeutic outcomes. Recent advances in nano-biomaterials have demonstrated promising regenerative potential compared to traditional treatments. This review discusses the progress of biomaterial-assisted macrophage targeting in chronic wound repair and addresses the challenges faced in its clinical application. Additionally, it explores novel design concepts for combinational therapies, such as incorporating regenerative particles like exosomes into dressing materials or encapsulating them in microneedling systems to enhance wound healing rates.

摘要

伤口愈合是一个动态的多阶段过程,对于恢复皮肤完整性至关重要。伤口愈合失调通常与巨噬细胞功能受损有关,尤其是在患有慢性基础疾病的个体中。巨噬细胞作为伤口愈合的关键调节因子,表现出显著的表型多样性,从促愈合的M2表型到促炎的M1表型。M1/M2比例失衡或M1表型的过度激活会延迟正常愈合。因此,旨在抑制M1表型或促进局部皮肤巨噬细胞向M2表型转变的策略可能有助于治疗慢性难愈合伤口。本文综述了巨噬细胞在正常和病理性伤口愈合过程中的作用。它研究了针对M2巨噬细胞的各种治疗方法,如体外激活巨噬细胞疗法、免疫药理学策略和生物材料导向的巨噬细胞极化。然而,它也强调了M2巨噬细胞疗法和免疫药理学干预可能存在缺点,包括快速的表型变化、对其他皮肤细胞的不利影响、生物毒性以及与生物相容性、稳定性和药物降解相关的问题。因此,需要更有针对性的基于巨噬细胞的疗法,以确保最佳的生物安全性,实现对失调巨噬细胞的有效重编程并改善治疗效果。与传统治疗相比,纳米生物材料的最新进展已显示出有前景的再生潜力。本综述讨论了生物材料辅助巨噬细胞靶向在慢性伤口修复中的进展,并阐述了其临床应用中面临的挑战。此外,它还探索了联合疗法的新颖设计概念,例如将外泌体等再生颗粒纳入敷料材料或封装在微针系统中以提高伤口愈合速度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验